| Citation: |
LIU Chengwei, WANG Kunyang, HU Zhen, LI Yaoping. Research Advances in Tetraspanins in Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2025, 52(5): 361-367. DOI: 10.3971/j.issn.1000-8578.2025.24.1255
|
The tetraspanins are closely associated with the development and therapeutic prognosis of colorectal tumors. These proteins play a role in cell proliferation, metastasis, and invasion, regulate apoptosis and autophagy of colorectal tumor cells. affect immune escape by releasing exosomes, intervening the epithelial-mesenchymal transition process, and altering the tumor microenvironment, and enhance tumor stemness through specific pathways. This paper reviews the mechanisms and current research regarding the status of tetraspanins in colorectal cancer, aiming to improve early diagnosis and providing valuable insights for treatment strategies.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
| [2] |
Becic A, Leifeld J, Shaukat J, et al. Tetraspanins as Potential Modulators of Glutamatergic Synaptic Function[J]. Front Mol Neurosci, 2022, 14: 801882. doi: 10.3389/fnmol.2021.801882
|
| [3] |
Susa KJ, Kruse AC, Blacklow SC. Tetraspanins: structure, dynamics, and principles of partner-protein recognition[J]. Trends Cell Biol, 2024, 34(6): 509-522. doi: 10.1016/j.tcb.2023.09.003
|
| [4] |
Zhou Z, Yang Z, Zhou L, et al. The versatile roles of testrapanins in cancer from intracellular signaling to cell-cell communication: cell membrane proteins without ligands[J]. Cell Biosci, 2023, 13(1): 59. doi: 10.1186/s13578-023-00995-8
|
| [5] |
Dharan R, Sorkin R. Tetraspanin proteins in membrane remodeling processes[J]. J Cell Sci, 2024, 137(14): jcs261532. doi: 10.1242/jcs.261532
|
| [6] |
Chen L, Yuan D, Zhao R, et al. Suppression of Tspan1 by RNA interference inhibits proliferation and invasion of colon cancer cells in vitro[J]. Tumori, 2010, 96(5): 744-750. doi: 10.1177/030089161009600517
|
| [7] |
Lee CH, Im EJ, Moon PG, et al. Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles[J]. BMC Cancer, 2018, 18(1): 1058. doi: 10.1186/s12885-018-4952-y
|
| [8] |
Roh S, Kim S, Hong I, et al. High Expression of Tetraspanin 5 as a Prognostic Marker of Colorectal Cancer[J]. Int J Mol Sci, 2023, 24(7): 6476. doi: 10.3390/ijms24076476
|
| [9] |
Liu J, Chen C, Li G, et al. Upregulation of Tspan12 is associated with the colorectal cancer growth and metastasis[J]. Am J Transl Res, 2017, 9(2): 812-822.
|
| [10] |
Andrijes R, Hejmadi RK, Pugh M, et al. Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer[J]. Proc Natl Acad Sci U S A, 2021, 118(39): e2011411118. doi: 10.1073/pnas.2011411118
|
| [11] |
Yan W, Huang J, Zhang Q, et al. Role of Metastasis Suppressor KAI1/CD82 in Different Cancers[J]. J Oncol, 2021, 2021: 9924473.
|
| [12] |
Ovalle S, Gutiérrez-López MD, Olmo N, et al. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells[J]. Int J Cancer, 2007, 121(10): 2140-2152. doi: 10.1002/ijc.22902
|
| [13] |
Shao S, Bu Z, Xiang J, et al. The role of Tetraspanins in digestive system tumor development: update and emerging evidence[J]. Front Cell Dev Biol, 2024, 12: 1343894. doi: 10.3389/fcell.2024.1343894
|
| [14] |
Guo Q, Xia B, Zhang F, et al. Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cell-cell adhesions[J]. PLoS One, 2012, 7(6): e38464. doi: 10.1371/journal.pone.0038464
|
| [15] |
Yang T, Wang H, Li M, et al. CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1[J]. Int J Biol Sci, 2021, 17(3): 848-860. doi: 10.7150/ijbs.53657
|
| [16] |
Erfani S, Hua H, Pan Y, et al. The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and Metastasis[J]. Cancers (Basel), 2021, 13(9): 2005. doi: 10.3390/cancers13092005
|
| [17] |
Kuhn S, Koch M, Nübel T, et al. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression[J]. Mol Cancer Res, 2007, 5(6): 553-567. doi: 10.1158/1541-7786.MCR-06-0384
|
| [18] |
Luan M, He X, Huang X, et al. The peptide mimicking small extracellular loop domain of CD82 inhibits tumor cell migration, adhesion and induces apoptosis by inhibiting integrin mediated signaling[J]. Biochem Biophys Res Commun, 2018, 503(4): 2206-2211. doi: 10.1016/j.bbrc.2018.06.139
|
| [19] |
Wu CY, Yan J, Yang YF, et al. Overexpression of KAI1 induces autophagy and increases MiaPaCa-2 cell survival through the phosphorylation of extracellular signal-regulated kinases[J]. Biochem Biophys Res Commun, 2011, 404(3): 802-808. doi: 10.1016/j.bbrc.2010.12.063
|
| [20] |
Zhu L, Chen Y, Du H, et al. N-glycosylation of CD82 at Asn157 is required for suppressing migration and invasion by reversing EMT via Wnt/β-catenin pathway in colon cancer[J]. Biochem Biophys Res Commun, 2022, 629: 121-127. doi: 10.1016/j.bbrc.2022.08.079
|
| [21] |
Kaprio T, Hagström J, Andersson LC, et al. Tetraspanin CD63 independently predicts poor prognosis in colorectal cancer[J]. Histol Histopathol, 2020, 35(8): 887-892.
|
| [22] |
Gurung S, Perocheau D, Touramanidou L, et al. The exosome journey: from biogenesis to uptake and intracellular signalling[J]. Cell Commun Signal, 2021, 19(1): 47. doi: 10.1186/s12964-021-00730-1
|
| [23] |
Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles[J]. Annu Rev Cell Dev Biol, 2014, 30: 255-289. doi: 10.1146/annurev-cellbio-101512-122326
|
| [24] |
Nicolini A, Ferrari P. Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy[J]. Front Immunol, 2024, 15: 1353787. doi: 10.3389/fimmu.2024.1353787
|
| [25] |
Schaper F, van Spriel AB. Antitumor Immunity Is Controlled by Tetraspanin Proteins[J]. Front Immunol, 2018, 9: 1185. doi: 10.3389/fimmu.2018.01185
|
| [26] |
Shen H, Atiyas Y, Yang Z, et al. Ultrasensitive quantification of PD-L1+ extracellular vesicles in melanoma patient plasma using a parallelized high throughput droplet digital assay[J]. Lab Chip, 2024, 24(14): 3403-3411. doi: 10.1039/D4LC00331D
|
| [27] |
Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy[J]. J Cell Physiol, 2019, 234(6): 8381-8395. doi: 10.1002/jcp.27740
|
| [28] |
Charrin S, Jouannet S, Boucheix C, et al. Tetraspanins at a glance[J]. J Cell Sci, 2014, 127(Pt 17): 3641-3648.
|
| [29] |
Takebe N, Harris PJ, Warren RQ, et al. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways[J]. Nat Rev Clin Oncol, 2011, 8(2): 97-106. doi: 10.1038/nrclinonc.2010.196
|
| [30] |
Zhao H, Ming T, Tang S, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target[J]. Mol Cancer, 2022, 21(1): 144. doi: 10.1186/s12943-022-01616-7
|
| [31] |
Zhu R, Gires O, Zhu L, et al. Tspan8 promotes cancer cell stemness via activation of sonic Hedgehog signaling[J]. Nat Commun, 2019, 10(1): 2863. doi: 10.1038/s41467-019-10739-3
|
| [32] |
Zhang H, Song Q, Shang K, et al. Tspan protein family: focusing on the occurrence, progression, and treatment of cancer[J]. Cell Death Discov, 2024, 10(1): 187. doi: 10.1038/s41420-024-01961-0
|
| [33] |
Rodrigues G, Hoshino A, Kenific CM, et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis[J]. Nat Cell Biol, 2019, 21(11): 1403-1412. doi: 10.1038/s41556-019-0404-4
|
| [34] |
Bonnet M, Maisonial-Besset A, Zhu Y, et al. Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029[J]. Cancers (Basel), 2019, 11(2): 179. doi: 10.3390/cancers11020179
|
| [35] |
Kim TK, Park CS, Jeoung MH, et al. Generation of a human antibody that inhibits Tspan8-mediated invasion of metastatic colorectal cancer cells[J]. Biochem Biophys Res Commun, 2015, 468(4): 774-780. doi: 10.1016/j.bbrc.2015.11.031
|
| [36] |
Kim SJ, Sun EG, Bae JA, et al. A peptide interfering with the dimerization of oncogenic KITENIN protein and its stability suppresses colorectal tumour progression[J]. Clin Transl Med, 2022, 12(7): e871. doi: 10.1002/ctm2.871
|
| [37] |
Bailly C, Thuru X. Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases[J]. Cancers (Basel), 2023, 15(7): 2186. doi: 10.3390/cancers15072186
|
| [38] |
Santos MF, Rappa G, Fontana S, et al. Anti-Human CD9 Fab Fragment Antibody Blocks the Extracellular Vesicle-Mediated Increase in Malignancy of Colon Cancer Cells[J]. Cells, 2022, 11(16): 2474. doi: 10.3390/cells11162474
|
| [39] |
Colbert JD, Cruz FM, Baer CE, et al. Tetraspanin-5-mediated MHC class Ⅰ clustering is required for optimal CD8 T cell activation[J]. Proc Natl Acad Sci U S A, 2022, 119(42): e2122188119. doi: 10.1073/pnas.2122188119
|
| [40] |
Rocha-Perugini V, Martínez Del Hoyo G, González-Granado JM, et al. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells[J]. Mol Cell Biol, 2017, 37(15): e00202-e00217.
|
| [41] |
Palmulli R, Couty M, Piontek MC, et al. CD63 sorts cholesterol into endosomes for storage and distribution via exosomes[J]. Nat Cell Biol, 2024, 26(7): 1093-1109. doi: 10.1038/s41556-024-01432-9
|
Figures(1) / Tables(4)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: